Literature DB >> 12899875

Modification of the functional capacity of sarcoplasmic reticulum membranes in patients suffering from chronic fatigue syndrome.

Stefania Fulle1, Silvia Belia, Jacopo Vecchiet, Caterina Morabito, Leonardo Vecchiet, Giorgio Fanò.   

Abstract

In chronic fatigue syndrome, several reported alterations may be related to specific oxidative modifications in muscle. Since sarcoplasmic reticulum membranes are the basic structures involved in excitation-contraction coupling and the thiol groups of Ca(2+) channels of SR terminal cisternae are specific targets for reactive oxygen species, it is possible that excitation-contraction coupling is involved in this pathology. We investigated the possibility that abnormalities in this compartment are involved in the pathogenesis of chronic fatigue syndrome and consequently responsible for characteristic fatigue. The data presented here support this hypothesis and indicate that the sarcolemmal conduction system and some aspects of Ca(2+) transport are negatively influenced in chronic fatigue syndrome. In fact, both deregulation of pump activities (Na(+)/K(+) and Ca(2+)-ATPase) and alteration in the opening status of ryanodine channels may result from increased membrane fluidity involving sarcoplasmic reticulum membranes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12899875     DOI: 10.1016/s0960-8966(03)00042-7

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

Review 1.  The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.

Authors:  Gerwyn Morris; Michael Berk; Piotr Galecki; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-01-20       Impact factor: 5.590

2.  Potential role of pioglitazone, caffeic acid and their combination against fatigue syndrome-induced behavioural, biochemical and mitochondrial alterations in mice.

Authors:  Anil Kumar; Aditi Vashist; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2010-07-03       Impact factor: 4.473

Review 3.  Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis.

Authors:  Stefania Fulle; Tiziana Pietrangelo; Rosa Mancinelli; Raoul Saggini; Giorgio Fanò
Journal:  J Muscle Res Cell Motil       Date:  2008-02-15       Impact factor: 2.698

4.  Increased activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase in the frontal cortex and cerebellum of autistic individuals.

Authors:  Lina Ji; Abha Chauhan; W Ted Brown; Ved Chauhan
Journal:  Life Sci       Date:  2009-10-26       Impact factor: 5.037

5.  Natural killer cells in patients with severe chronic fatigue syndrome.

Authors:  E W Brenu; S L Hardcastle; G M Atkinson; M L van Driel; S Kreijkamp-Kaspers; K J Ashton; D R Staines; S M Marshall-Gradisnik
Journal:  Auto Immun Highlights       Date:  2013-04-16

Review 6.  Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases.

Authors:  David Maughan; Michael Toth
Journal:  Biology (Basel)       Date:  2014-09-22

7.  New insights into the relationship between mIGF-1-induced hypertrophy and Ca2+ handling in differentiated satellite cells.

Authors:  Simone Guarnieri; Caterina Morabito; Silvia Belia; Laura Barberi; Antonio Musarò; Giorgio Fanò-Illic; Maria A Mariggiò
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

Review 8.  Understanding Muscle Dysfunction in Chronic Fatigue Syndrome.

Authors:  Gina Rutherford; Philip Manning; Julia L Newton
Journal:  J Aging Res       Date:  2016-02-22

Review 9.  Age-related changes in skeletal muscle: changes to life-style as a therapy.

Authors:  Rachel McCormick; Aphrodite Vasilaki
Journal:  Biogerontology       Date:  2018-09-27       Impact factor: 4.277

10.  Old muscle in young body: an aphorism describing the Chronic Fatigue Syndrome.

Authors:  Tiziana Pietrangelo; Stefania Fulle; Francesco Coscia; Paola Virginia Gigliotti; Giorgio Fanò-Illic
Journal:  Eur J Transl Myol       Date:  2018-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.